5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma
March 16, 2022 07:00 ET | Todos Medical Ltd.
- Forms new subsidiary, 3CL Pharma, focused on the development and commercialization of 3CL protease-related products including Tollovir™, Tollovid®, Tollovid Daily™ and TolloTest™ for COVID-19 - ...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Announces Tollovid® Products Exclusive License & Distribution Agreement with T-Cell Protect Hellas S.A. Covering 30 Countries in Europe
November 18, 2021 06:00 ET | Todos Medical Ltd.
The Agreement Calls for a Minimum of 500,000 Bottles in Sales Over 18 Months T-Cell Protect to Invest 1 Million Euros in Todos to Support Development of Tollovir, the Company’s 3CL Protease...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Enters Into Automation and Reagent Supply Agreement with MAJL Diagnostics
March 23, 2021 08:00 ET | Todos Medical Ltd.
NEW YORK, NY, REHOVAT, ISRAEL, and ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Announces Instrument Validation Complete at MOTO+PARA Mobile Lab
October 26, 2020 07:30 ET | Todos Medical Ltd.
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive...
5e70ba2109b32d0004a916bd_1.jpg
Pathnova Laboratories (PATHNOVA) Enters into Partnership to Commercialize Todos Medicals COVID-19 and Breast Cancer Tests in Singapore
August 03, 2020 07:00 ET | Todos Medical Ltd.
Temasek Life Sciences Accelerator-backed PATHNOVA to Offer COVID-19 Testing Kits Supplied by Todos in Singapore and Southeast Asia REHOVOT, Israel, SINGAPORE and NEW YORK, NY, Aug. 03, 2020 ...
5e70ba2109b32d0004a916bd_1.jpg
Nationwide On-Site Coronavirus Testing Program
July 06, 2020 07:00 ET | Todos Medical Ltd.
REHOVOT, ISRAEL, July 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Meridian HSN has partnered with Moto-Para and Todos Medical (OTCQB: TOMDF) to provide a complete turnkey solution for on-site...
TodosMedical.png
Todos To Present At Upcoming 12th Annual LD Micro Main Event
December 06, 2019 07:29 ET | Todos Medical Ltd.
REHOVOT, Israel, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
TodosMedical.png
Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET
November 14, 2019 11:02 ET | Todos Medical Ltd.
Topline results expected before the end of Q1/2020 REHOVOT, Israel and NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company...
TodosMedical.png
Todos Medical and Orot+ Announce First Patient Enrolled in Pre-Commercial Launch Preparations of TM-B1 and TM-B2 Breast Cancer Blood Screening Tests in Europe
September 24, 2019 09:14 ET | Todos Medical Ltd.
REHOVOT, Israel, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
TodosMedical.png
Todos Medical Receives Notice of Allowance from the USPTO Covering the Early Diagnosis of Lung Cancer Using the Todos Biochemical Infrared Analysis (TBIA)
May 01, 2019 08:00 ET | Todos Medical Ltd.
REHOVOT, Israel and NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the...